considered as an "emerging biomarker" in COPD. PIFR, the maximal airflow generated during inspiration, is a physiological measure that fits the definition of a biomarker (1) . A suboptimal PIFRr value (,60 L/min) can identify individuals who are more likely to experience a less than favorable response to a dry-powder bronchodilator compared with those who exhibit an optimal PIFRr (>60 L/min). The following information follows biomarker development steps (1).
Identify an Unmet Need
According to the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD), pharmacotherapy for COPD should be individualized based on the severity of symptoms and risk of exacerbations (2) . However, neither the GOLD strategy nor guidelines on COPD offer specific recommendations about which of the four delivery systems to use in which types of patients to achieve clinical efficacy. Patient factors for optimal drug delivery include the patient's inspiratory flow rate, flow acceleration rate, time of inhalation, inhaled volume, and breathhold time. For DPIs, higher inspiratory flows increase the fine particle fraction of the medication reaching the lungs. The unmet need is the ability to predict which patients are unlikely to respond optimally to a dry-powder medication (i.e., those with a suboptimal PIFRr). DPIs are prescribed widely throughout the world to treat COPD. Each DPI has a unique internal resistance. The recommended use of dry-powder medications requires the patient to inhale "hard and fast" to create turbulent forces within the device to disaggregate the powder into fine particles (,5 mg in diameter) that are then inhaled into the lungs. PIFRr is determined by an individual's effort and respiratory muscle strength.
Intended Use Population
PIFRr is intended as a biomarker in COPD. It may also be considered for use in other patients, such as those with asthma or cystic fibrosis, who use DPIs.
Biomarker Discovery
The
Analytic Validation
The In-Check DIAL (Clement Clerke International Ltd.) has been used widely in studies to measure PIFRr (4-6, 8, 9) . It is portable and provides an adjustable dial to simulate different DPI resistances. Although accuracy and reliability of PIFRr have been reported in patients with COPD (4), confirmation is required in larger patient populations.
Clinical Validation
The clinical phenotype of patients with a suboptimal PIFRr includes older age, female sex, and reduced inspiratory capacity, a marker of lung hyperinflation (4) . A suboptimal PIFRr is common, being reported in 19-100% of stable outpatients (six studies) and 32-52% of inpatients (three studies) before discharge after admission to the hospital for an exacerbation (4-7). These wide ranges reflect measurements with different DPI resistances in different COPD populations. Two randomized controlled trials demonstrated that patients with severe to very severe COPD and a suboptimal PIFRr against the Diskus had greater improvements in lung function with a bronchodilator delivered by nebulization compared with a DPI (8, 9) .
Additional Evidence Is Needed
To establish broad clinical application of the PIFRr, additional randomized controlled trials in both inpatients and outpatients are needed. For example, to reduce readmissions, many hospitals include measurement of the PIFRr before discharging a patient after a COPD exacerbation. A non-DPI delivery system is selected if the PIFRr is suboptimal. If the evidence shows greater bronchodilation and/or reduced readmissions with a non-DPI delivery system compared with a DPI in patients with a suboptimal PIFRr, then measurement of the PIFRr can be recommended in guidelines/strategies for COPD. n To the Editor:
We read with interest Jubran and colleagues' article titled "Long-term outcome after prolonged mechanical ventilation: a long-term acutecare hospital study" (1). As critical-care survivorship increases, we will increasingly need to confront the issue of whether interventions made in extremis result in outcomes consistent with the long-term wishes of patients. Jubran and colleagues' findings that more than half of the patients in their study were detached from a ventilator by discharge from a long-term acute-care hospital, and that 85% of survivors of prolonged mechanical ventilation would choose to again undergo prolonged ventilation could potentially inform decisionmaking regarding prolonged mechanical ventilation. However, to apply the findings of Jubran and colleagues to patient care, it is necessary to understand the selection process by which patients were enrolled in the clinical trial on which the study was based (2) .
Our interpretation of the original randomized trial's Consolidated Standards of Reporting Trials flow diagram is that 2,267 patients were screened and 316 were enrolled, and these 316 patients represent the cohort included in the current secondary observational analysis. Acknowledging the challenges of enrolling patients with prolonged mechanical ventilation in a randomized trial, we note that most patients were excluded from the trial owing to an inability or refusal to consent, and many others were excluded owing to profound neurologic deficits or a life expectancy of ,3 months. We wonder if the exclusion of most long-term acute-care hospital patients-the 316 patients enrolled reflect less than 14% of the originally screened sample-introduced substantial selection bias into the estimates of ventilator liberation and patient satisfaction. We speculate that the excluded patients had disease characteristics (including an inability to participate in handgrip, maximum inspiratory pressure maneuvers, or quality-of-life and preference questionnaires) that would decrease the total proportion of patients detached from the ventilator, leading to different conclusions. Could the authors expand upon how their results should be interpreted in light of the narrow selection criteria that led patients to participate in the original trial?
Finally, we noted also that the authors invoked Daniel Kahneman's "experiencing self" and "remembering self" in the context of 85% of survivors being "willing to [again] undergo a further episode of prolonged ventilation." We wish to note that only survivors-and only those with an intact mental status, at that-are afforded the opportunity to convey a remembering self. It is impossible to ask either decedents or survivors without an intact 
